日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Viruses and thrombocytopenia

病毒和血小板减少症

Rasizadeh, Reyhaneh; Ebrahimi, Fatemeh; Zamani Kermanshahi, Atefeh; Daei Sorkhabi, Amin; Sarkesh, Aila; Sadri Nahand, Javid; Bannazadeh Baghi, Hossein

Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges

阿尔茨海默病:流行病学、危险因素、症状、诊断、管理、照护、先进疗法及相关挑战的全面综述

Safiri, Saeid; Ghaffari Jolfayi, Amir; Fazlollahi, Asra; Morsali, Soroush; Sarkesh, Aila; Daei Sorkhabi, Amin; Golabi, Behnam; Aletaha, Reza; Motlagh Asghari, Kimia; Hamidi, Sana; Mousavi, Seyed Ehsan; Jamalkhani, Sepehr; Karamzad, Nahid; Shamekh, Ali; Mohammadinasab, Reza; Sullman, Mark J M; Şahin, Fikrettin; Kolahi, Ali-Asghar

Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice

基于免疫检查点的免疫疗法在多发性硬化症治疗中的进展:理论基础与实践

Daei Sorkhabi, Amin; Komijani, Erfan; Sarkesh, Aila; Ghaderi Shadbad, Pedram; Aghebati-Maleki, Ali; Aghebati-Maleki, Leili

Current status of skin cancers with a focus on immunology and immunotherapy

皮肤癌的现状,重点关注免疫学和免疫疗法

Khayyati Kohnehshahri, Mahsa; Sarkesh, Aila; Mohamed Khosroshahi, Leila; HajiEsmailPoor, Zanyar; Aghebati-Maleki, Ali; Yousefi, Mehdi; Aghebati-Maleki, Leili

The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

CAR-T细胞疗法治疗实体瘤的现状:机制、研究进展、挑战和应对策略

Daei Sorkhabi, Amin; Mohamed Khosroshahi, Leila; Sarkesh, Aila; Mardi, Amirhossein; Aghebati-Maleki, Ali; Aghebati-Maleki, Leili; Baradaran, Behzad

The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials

替雷利珠单抗单药或联合化疗治疗非小细胞肺癌的安全性和有效性:临床试验的系统评价

Daei Sorkhabi, Amin; ZareDini, Mahta; Fazlollahi, Asra; Sarkesh, Aila; Naseri, Amirreza; Mousavi, Seyed Ehsan; Nejadghaderi, Seyed Aria; Sullman, Mark J M; Kolahi, Ali-Asghar; Safiri, Saeid

Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials

维利帕尼联合化疗治疗肺癌的疗效和安全性:临床试验的系统评价

Daei Sorkhabi, Amin; Fazlollahi, Asra; Sarkesh, Aila; Aletaha, Reza; Feizi, Hamidreza; Mousavi, Seyed Ehsan; Nejadghaderi, Seyed Aria; Sullman, Mark J M; Kolahi, Ali-Asghar; Safiri, Saeid

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

自身免疫性疾病中靶向Survivin的microRNA失调:新型疗法的新视角

Shomali, Navid; Suliman Maashi, Marwah; Baradaran, Behzad; Daei Sorkhabi, Amin; Sarkesh, Aila; Mohammadi, Hamed; Hemmatzadeh, Maryam; Marofi, Faroogh; Sandoghchian Shotorbani, Siamak; Jarahian, Mostafa

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

巨细胞病毒特异性细胞毒性T细胞免疫疗法在胶质母细胞瘤临床应用的基础和进展

Daei Sorkhabi, Amin; Sarkesh, Aila; Saeedi, Hossein; Marofi, Faroogh; Ghaebi, Mahnaz; Silvestris, Nicola; Baradaran, Behzad; Brunetti, Oronzo

Extrapulmonary Clinical Manifestations in COVID-19 Patients

新冠肺炎患者的肺外临床表现

Sarkesh, Aila; Daei Sorkhabi, Amin; Sheykhsaran, Elham; Alinezhad, Farbod; Mohammadzadeh, Nader; Hemmat, Nima; Bannazadeh Baghi, Hossein